0001053369-14-000014.txt : 20140117
0001053369-14-000014.hdr.sgml : 20140117
20140117191322
ACCESSION NUMBER: 0001053369-14-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140113
FILED AS OF DATE: 20140117
DATE AS OF CHANGE: 20140117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/
CENTRAL INDEX KEY: 0001053369
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223542636
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
BUSINESS PHONE: 2017502646
MAIL ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
FORMER COMPANY:
FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/
DATE OF NAME CHANGE: 19980121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NARINE JEENARINE
CENTRAL INDEX KEY: 0001465822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15697
FILM NUMBER: 14536331
MAIL ADDRESS:
STREET 1: C/O EPIC PHARMA, LLC
STREET 2: 227-15 NORTH CONDUIT AVENUE
CITY: LAURELTON
STATE: NY
ZIP: 11413
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-01-13
0
0001053369
ELITE PHARMACEUTICALS INC /NV/
ELTP
0001465822
NARINE JEENARINE
C/O EPIC PHARMA, LLC
227-15 NORTH CONDUIT AVENUE
LAURELTON
NY
11413
1
0
1
0
Common Stock
2014-01-13
4
S
0
805583
0.183
D
15341280
I
By Epic Investments, LLC
Common Stock
5957622
D
Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
Jeenarine Narine
2014-01-17